CEFEPIME HYDROCHLORIDE

CEFEPIME HYDROCHLORIDE was reported 16330 times

CEFEPIME HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MENINGITIS CANDIDA 11 0.1571
1 BURKHOLDERIA TEST POSITIVE 18 0.1452
2 CORYNEBACTERIUM BACTERAEMIA 11 0.1294
3 TRICHOSPORON INFECTION 30 0.0741
4 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 28 0.0690
5 AEROMONAS INFECTION 13 0.0688
6 HEPATOSPLENIC CANDIDIASIS 10 0.0680
7 CUTANEOUS MUCORMYCOSIS 12 0.0652
8 HYPEROXALURIA 9 0.0523
9 URAEMIC ENCEPHALOPATHY 16 0.0511
10 PHRENIC NERVE PARALYSIS 11 0.0502
11 GEOTRICHUM INFECTION 10 0.0474
12 NAIL BED INFLAMMATION 15 0.0470
13 CNS VENTRICULITIS 15 0.0460
14 SEPTIC EMBOLUS 38 0.0457
15 ENGRAFT FAILURE 13 0.0453
16 HUMAN EHRLICHIOSIS 9 0.0431
17 FUNGAEMIA 63 0.0400
18 DISSEMINATED MUCORMYCOSIS 15 0.0381
19 ENTEROCOCCAL BACTERAEMIA 39 0.0368
20 CEREBRAL ASPERGILLOSIS 22 0.0358
21 NEPHRITIS ALLERGIC 14 0.0353
22 VANCOMYCIN INFUSION REACTION 13 0.0345
23 EYE INFECTION FUNGAL 13 0.0336
24 PNEUMONIA NECROTISING 20 0.0309
25 STENOTROPHOMONAS INFECTION 41 0.0302
26 FUSARIUM INFECTION 21 0.0300
27 ENTEROBACTER BACTERAEMIA 9 0.0297
28 DIFFERENTIATION SYNDROME 21 0.0286
29 CORYNEBACTERIUM INFECTION 15 0.0280
30 CYTOKINE STORM 19 0.0277
31 ENGRAFTMENT SYNDROME 16 0.0271
32 UREAPLASMA INFECTION 11 0.0270
33 BLASTOMYCOSIS 13 0.0267
34 ENTEROCOCCUS TEST POSITIVE 17 0.0262
35 CYTOMEGALOVIRUS ENTEROCOLITIS 20 0.0260
36 METHAEMOGLOBINAEMIA 60 0.0259
37 CRYSTALLURIA 14 0.0257
38 GLOMERULOSCLEROSIS 16 0.0253
39 DYSBIOSIS 20 0.0244
40 NEUTROPENIC COLITIS 50 0.0242
41 NASAL MUCOSAL DISORDER 14 0.0240
42 ENCEPHALOPATHY 568 0.0231
43 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 178 0.0229
44 PULMONARY MUCORMYCOSIS 12 0.0227
45 MUCORMYCOSIS 59 0.0227
46 DISSEMINATED CRYPTOCOCCOSIS 17 0.0225
47 ECTHYMA 9 0.0224
48 CYTOMEGALOVIRUS TEST POSITIVE 40 0.0224
49 PSEUDOMONAL SEPSIS 39 0.0222
50 ENTEROCOCCAL SEPSIS 18 0.0222
51 SPUTUM CULTURE POSITIVE 18 0.0222
52 ENTEROCOCCAL INFECTION 107 0.0221
53 URINARY TRACT INFECTION PSEUDOMONAL 13 0.0216
54 PROCALCITONIN INCREASED 25 0.0213
55 PSEUDOMONAL BACTERAEMIA 18 0.0211
56 MEDIASTINITIS 12 0.0207
57 BACILLUS INFECTION 13 0.0206
58 NECROTISING RETINITIS 13 0.0203
59 TOXIC ENCEPHALOPATHY 102 0.0201
60 ACUTE MYELOID LEUKAEMIA RECURRENT 43 0.0200
61 CAECITIS 9 0.0200
62 ENTEROBACTER INFECTION 33 0.0196
63 PNEUMONIA PSEUDOMONAL 30 0.0195
64 RED MAN SYNDROME 17 0.0193
65 CHOLESTATIC LIVER INJURY 43 0.0193
66 DIFFUSE ALVEOLAR DAMAGE 22 0.0191
67 SYSTEMIC CANDIDA 47 0.0187
68 PSEUDOMONAS TEST POSITIVE 15 0.0183
69 NEUROTOXICITY 321 0.0183
70 ACINETOBACTER INFECTION 20 0.0183
71 KLEBSIELLA INFECTION 92 0.0182
72 LINEAR IGA DISEASE 30 0.0180
73 RETINAL ISCHAEMIA 11 0.0180
74 SYSTEMIC MYCOSIS 21 0.0180
75 BLOOD CULTURE POSITIVE 52 0.0174
76 ABDOMINAL COMPARTMENT SYNDROME 11 0.0173
77 SJS-TEN OVERLAP 12 0.0171
78 MITOCHONDRIAL TOXICITY 14 0.0171
79 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 101 0.0170
80 METABOLIC ENCEPHALOPATHY 51 0.0170
81 CLOSTRIDIUM DIFFICILE COLITIS 180 0.0170
82 BOTULISM 14 0.0169
83 KLEBSIELLA TEST POSITIVE 11 0.0169
84 DIAPHRAGMATIC PARALYSIS 10 0.0167
85 SPUTUM ABNORMAL 11 0.0166
86 MENINGITIS BACTERIAL 23 0.0161
87 CYTOKINE RELEASE SYNDROME 322 0.0160
88 STREPTOCOCCAL SEPSIS 19 0.0160
89 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 13 0.0158
90 KLEBSIELLA BACTERAEMIA 15 0.0158
91 PSEUDOMONAS INFECTION 135 0.0157
92 BRAIN HERNIATION 47 0.0157
93 PSEUDOMEMBRANOUS COLITIS 35 0.0157
94 STREPTOCOCCAL BACTERAEMIA 17 0.0156
95 RASH MORBILLIFORM 43 0.0155
96 RENAL TUBULAR NECROSIS 152 0.0155
97 JARISCH-HERXHEIMER REACTION 11 0.0154
98 STATUS EPILEPTICUS 174 0.0154
99 MYCOBACTERIUM ABSCESSUS INFECTION 11 0.0154
100 STAPHYLOCOCCUS TEST POSITIVE 32 0.0152
101 EOSINOPHILIC PNEUMONIA ACUTE 13 0.0150
102 BRONCHOPULMONARY ASPERGILLOSIS 116 0.0149
103 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 383 0.0149
104 CANDIDA SEPSIS 13 0.0145
105 PNEUMONIA FUNGAL 57 0.0144
106 TRACHEOBRONCHITIS 11 0.0143
107 SUBCUTANEOUS EMPHYSEMA 14 0.0143
108 MYOCLONUS 167 0.0140
109 MIXED LIVER INJURY 42 0.0139
110 SINUSITIS FUNGAL 11 0.0137
111 ESCHERICHIA BACTERAEMIA 32 0.0136
112 CLOSTRIDIUM TEST POSITIVE 30 0.0136
113 RESPIRATORY ALKALOSIS 22 0.0135
114 CULTURE URINE POSITIVE 19 0.0135
115 PATHOGEN RESISTANCE 123 0.0135
116 SERRATIA INFECTION 10 0.0134
117 FEBRILE NEUTROPENIA 887 0.0134
118 IMMUNE THROMBOCYTOPENIA 61 0.0133
119 BACTERAEMIA 158 0.0133
120 CONTINUOUS HAEMODIAFILTRATION 13 0.0133
121 VENOOCCLUSIVE LIVER DISEASE 65 0.0131
122 CYTOMEGALOVIRUS VIRAEMIA 58 0.0130
123 STRONGYLOIDIASIS 21 0.0130
124 ASPERGILLUS INFECTION 84 0.0128
125 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 12 0.0127
126 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 35 0.0126
127 MULTIPLE ORGAN DYSFUNCTION SYNDROME 358 0.0126
128 HYPERCAPNIA 38 0.0126
129 PNEUMOCYSTIS JIROVECII INFECTION 15 0.0126
130 SLOW RESPONSE TO STIMULI 16 0.0123
131 FUNGAL SEPSIS 10 0.0120
132 PNEUMONIA KLEBSIELLA 22 0.0120
133 VASCULAR DEVICE INFECTION 54 0.0119
134 SEPTIC SHOCK 516 0.0118
135 CATHETER RELATED INFECTION 12 0.0118
136 PNEUMONIA CYTOMEGALOVIRAL 23 0.0118
137 PNEUMONIA STAPHYLOCOCCAL 23 0.0116
138 INTRACRANIAL MASS 11 0.0116
139 CLOSTRIDIAL INFECTION 39 0.0115
140 BLAST CELL COUNT INCREASED 12 0.0115
141 DEVICE RELATED SEPSIS 23 0.0114
142 ACUTE RESPIRATORY DISTRESS SYNDROME 202 0.0114
143 LARGE INTESTINE INFECTION 14 0.0114
144 HYPERTENSIVE HEART DISEASE 21 0.0112
145 INFECTIOUS PLEURAL EFFUSION 17 0.0112
146 NEPHROPATHY TOXIC 125 0.0111
147 EOSINOPHILIC PNEUMONIA 35 0.0111
148 PNEUMOMEDIASTINUM 20 0.0111
149 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 83 0.0110
150 STAPHYLOCOCCAL BACTERAEMIA 48 0.0110
151 NOCARDIOSIS 28 0.0109
152 ELECTROCARDIOGRAM T WAVE ABNORMAL 17 0.0109
153 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 10 0.0108
154 URINARY TRACT INFECTION ENTEROCOCCAL 10 0.0107
155 HISTOPLASMOSIS DISSEMINATED 17 0.0107
156 CEREBRAL ARTERY EMBOLISM 13 0.0107
157 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 15 0.0106
158 MENTAL STATUS CHANGES 292 0.0105
159 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 40 0.0105
160 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 27 0.0105
161 EPIDERMAL NECROSIS 10 0.0103
162 ISCHAEMIC HEPATITIS 14 0.0102
163 HYPORESPONSIVE TO STIMULI 12 0.0102
164 TUBULOINTERSTITIAL NEPHRITIS 191 0.0102
165 RETROPERITONEAL HAEMATOMA 22 0.0099
166 AUTOIMMUNE HAEMOLYTIC ANAEMIA 34 0.0099
167 BRAIN ABSCESS 25 0.0099
168 VANISHING BILE DUCT SYNDROME 11 0.0099
169 ACUTE RESPIRATORY FAILURE 188 0.0098
170 LUNG CONSOLIDATION 27 0.0096
171 HENOCH-SCHONLEIN PURPURA 21 0.0096
172 HAEMODYNAMIC INSTABILITY 73 0.0096
173 DISSEMINATED INTRAVASCULAR COAGULATION 130 0.0092
174 HAEMOPHILUS INFECTION 9 0.0092
175 MULTIPLE-DRUG RESISTANCE 28 0.0090
176 PERIRECTAL ABSCESS 10 0.0090
177 PULSELESS ELECTRICAL ACTIVITY 37 0.0088
178 HAEMODIALYSIS 74 0.0088
179 BLOOD FIBRINOGEN DECREASED 10 0.0088
180 TOXIC EPIDERMAL NECROLYSIS 133 0.0087
181 NEPHRITIS INTERSTITIAL 11 0.0087
182 KIDNEY FIBROSIS 15 0.0086
183 EOSINOPHILIA 151 0.0086
184 ACUTE KIDNEY INJURY 1289 0.0084
185 TUMOUR LYSIS SYNDROME 74 0.0084
186 LIVER ABSCESS 27 0.0083
187 ORGANISING PNEUMONIA 41 0.0083
188 PHARYNGEAL INFLAMMATION 10 0.0082
189 CAPILLARY LEAK SYNDROME 17 0.0082
190 NOSOCOMIAL INFECTION 18 0.0082
191 ENTEROCOLITIS 47 0.0081
192 HYPOXIA 283 0.0080
193 CANDIDA INFECTION 135 0.0080
194 ACIDOSIS 61 0.0080
195 HEPARIN-INDUCED THROMBOCYTOPENIA 39 0.0079
196 STAPHYLOCOCCAL SEPSIS 39 0.0079
197 CEREBRAL VENTRICLE DILATATION 9 0.0078
198 HISTIOCYTOSIS HAEMATOPHAGIC 23 0.0077
199 DRUG RESISTANCE 197 0.0077
200 VENOOCCLUSIVE DISEASE 19 0.0076
201 ESCHERICHIA TEST POSITIVE 9 0.0075
202 LEUKOCYTOSIS 136 0.0075
203 DISTRIBUTIVE SHOCK 17 0.0075
204 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 38 0.0075
205 HYPERPHOSPHATAEMIA 16 0.0074
206 NECROTISING FASCIITIS 26 0.0074
207 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 17 0.0073
208 LUNG INFILTRATION 64 0.0072
209 PNEUMONIA VIRAL 23 0.0072
210 ACUTE GRAFT VERSUS HOST DISEASE 33 0.0072
211 PULMONARY HAEMORRHAGE 56 0.0072
212 HEPATOSPLENOMEGALY 18 0.0070
213 ELECTROENCEPHALOGRAM ABNORMAL 22 0.0070
214 DRUG CLEARANCE DECREASED 9 0.0069
215 SPLENIC INFARCTION 12 0.0069
216 HYPERSENSITIVITY VASCULITIS 18 0.0068
217 STREPTOCOCCAL INFECTION 38 0.0068
218 DRUG LEVEL INCREASED 113 0.0068
219 MULTI-ORGAN FAILURE 118 0.0068
220 HYPERNATRAEMIA 34 0.0068
221 AGRANULOCYTOSIS 126 0.0068
222 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 18 0.0068
223 ATELECTASIS 65 0.0067
224 MYCOBACTERIUM AVIUM COMPLEX INFECTION 18 0.0067
225 GRAFT VERSUS HOST DISEASE 48 0.0067
226 RASH MACULO-PAPULAR 148 0.0066
227 PNEUMONIA BACTERIAL 61 0.0066
228 APLASIA 13 0.0066
229 ADENOVIRUS INFECTION 19 0.0065
230 ACUTE MYELOID LEUKAEMIA 102 0.0065
231 RESPIRATORY FAILURE 474 0.0065
232 LOBAR PNEUMONIA 12 0.0065
233 CLOSTRIDIUM DIFFICILE INFECTION 141 0.0065
234 ENDOCARDITIS 33 0.0064
235 GRAFT VERSUS HOST DISEASE IN SKIN 14 0.0063
236 HYPERTRANSAMINASAEMIA 44 0.0063
237 CHOLESTASIS 121 0.0063
238 BACTERIAL SEPSIS 20 0.0061
239 CRYPTOCOCCOSIS 10 0.0061
240 CYTOMEGALOVIRUS COLITIS 14 0.0061
241 SERUM FERRITIN INCREASED 32 0.0061
242 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 20 0.0060
243 HERPES SIMPLEX 39 0.0060
244 SHOCK 137 0.0060
245 CYSTITIS HAEMORRHAGIC 24 0.0059
246 APLASTIC ANAEMIA 31 0.0059
247 URINARY TRACT INFECTION BACTERIAL 15 0.0059
248 PANCYTOPENIA 327 0.0058
249 CHOREA 10 0.0058
250 CUTANEOUS VASCULITIS 21 0.0057
251 DERMATITIS EXFOLIATIVE GENERALISED 20 0.0057
252 INHIBITORY DRUG INTERACTION 9 0.0057
253 ACUTE LYMPHOCYTIC LEUKAEMIA 16 0.0056
254 PURPURA 50 0.0056
255 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 12 0.0056
256 OLIGURIA 35 0.0056
257 HYPOVOLAEMIC SHOCK 27 0.0056
258 DIPLEGIA 11 0.0056
259 SEPSIS 619 0.0055
260 PERIODONTITIS 12 0.0055
261 EMPYEMA 11 0.0055
262 HYPERBILIRUBINAEMIA 57 0.0055
263 BRAIN DEATH 17 0.0055
264 PNEUMOCYSTIS JIROVECII PNEUMONIA 55 0.0055
265 DRUG LEVEL ABOVE THERAPEUTIC 25 0.0055
266 PERIPHERAL ISCHAEMIA 22 0.0054
267 RESPIRATORY DISTRESS 148 0.0054
268 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 29 0.0053
269 BLOOD PH DECREASED 9 0.0053
270 AZOTAEMIA 21 0.0053
271 HYPERAMMONAEMIA 26 0.0052
272 ABSCESS LIMB 22 0.0052
273 HYPOALBUMINAEMIA 40 0.0051
274 RENAL FAILURE ACUTE 218 0.0051
275 DERMATITIS BULLOUS 37 0.0051
276 KYPHOSIS 9 0.0051
277 STEVENS-JOHNSON SYNDROME 113 0.0051
278 NEUTROPHIL COUNT DECREASED 207 0.0051
279 BLOOD UREA INCREASED 85 0.0051
280 PLEURITIC PAIN 14 0.0051
281 BRAIN OEDEMA 64 0.0051
282 STAPHYLOCOCCAL INFECTION 167 0.0051
283 HYPERVOLAEMIA 25 0.0051
284 SKIN NECROSIS 26 0.0050
285 ANURIA 43 0.0050
286 PULMONARY ALVEOLAR HAEMORRHAGE 28 0.0050
287 THROMBOCYTOPENIA 558 0.0050
288 HYPERTHERMIA 38 0.0050
289 DRUG ERUPTION 88 0.0050
290 GASTROINTESTINAL ULCER 11 0.0050
291 IMMUNE THROMBOCYTOPENIC PURPURA 14 0.0049
292 DEVICE RELATED INFECTION 76 0.0049
293 UNRESPONSIVE TO STIMULI 127 0.0049
294 COVID-19 PNEUMONIA 58 0.0049
295 THROMBOTIC THROMBOCYTOPENIC PURPURA 17 0.0048
296 INTRAVENTRICULAR HAEMORRHAGE 12 0.0048
297 THROMBOTIC MICROANGIOPATHY 47 0.0048
298 TACHYPNOEA 65 0.0048
299 LUNG ABSCESS 10 0.0048
300 CLONUS 13 0.0047
301 CREATININE RENAL CLEARANCE DECREASED 19 0.0047
302 HYPOGAMMAGLOBULINAEMIA 31 0.0047
303 OSTEOMYELITIS 84 0.0046
304 ENDOTRACHEAL INTUBATION 13 0.0046
305 HEPATIC LESION 20 0.0046
306 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 23 0.0046
307 DRUG-INDUCED LIVER INJURY 144 0.0046
308 RESPIRATORY ACIDOSIS 18 0.0046
309 PNEUMATOSIS INTESTINALIS 13 0.0046
310 RASH PUSTULAR 33 0.0045
311 ESCHERICHIA SEPSIS 13 0.0045
312 HEPATIC CYTOLYSIS 57 0.0045
313 MUCOSAL INFLAMMATION 117 0.0045
314 BK VIRUS INFECTION 15 0.0044
315 HEPATOCELLULAR INJURY 63 0.0044
316 WOUND DEHISCENCE 15 0.0044
317 LACTIC ACIDOSIS 143 0.0044
318 STEM CELL TRANSPLANT 11 0.0044
319 HAEMOLYTIC ANAEMIA 39 0.0043
320 PANCREATITIS NECROTISING 10 0.0043
321 LEFT VENTRICULAR DYSFUNCTION 29 0.0043
322 PARONYCHIA 19 0.0043
323 COAGULOPATHY 72 0.0043
324 CARDIAC DYSFUNCTION 16 0.0043
325 DIALYSIS 61 0.0043
326 METABOLIC ACIDOSIS 137 0.0043
327 AORTIC ARTERIOSCLEROSIS 11 0.0043
328 HYPOVOLAEMIA 25 0.0043
329 RENAL TUBULAR DISORDER 12 0.0043
330 NEUTROPHILIA 24 0.0042
331 PULSE ABSENT 20 0.0042
332 GENERALISED OEDEMA 52 0.0042
333 ENCEPHALITIS 29 0.0042
334 LUNG OPACITY 11 0.0042
335 TOXIC SKIN ERUPTION 42 0.0042
336 CEREBRAL HAEMATOMA 14 0.0042
337 CYTOPENIA 51 0.0042
338 COLITIS ISCHAEMIC 28 0.0041
339 HAEMOLYSIS 32 0.0041
340 HAEMOTHORAX 12 0.0041
341 STRESS CARDIOMYOPATHY 24 0.0041
342 PLEURAL EFFUSION 251 0.0041
343 NEUTROPENIA 558 0.0041
344 CYTOMEGALOVIRUS INFECTION REACTIVATION 18 0.0041
345 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 223 0.0041
346 NEUTROPENIC SEPSIS 29 0.0041
347 SHOCK HAEMORRHAGIC 33 0.0040
348 LARGE INTESTINAL ULCER 11 0.0040
349 BACTERIAL TEST POSITIVE 9 0.0040
350 ASPARTATE AMINOTRANSFERASE INCREASED 214 0.0040
351 BLOOD CREATININE INCREASED 263 0.0040
352 BACTERIAL INFECTION 75 0.0040
353 OESOPHAGEAL CANDIDIASIS 16 0.0040
354 ESCHERICHIA INFECTION 33 0.0040
355 CATHETER SITE HAEMORRHAGE 10 0.0040
356 BLOOD LACTIC ACID INCREASED 21 0.0040
357 SMALL INTESTINAL OBSTRUCTION 49 0.0040
358 SINUS TACHYCARDIA 56 0.0039
359 HYPERURICAEMIA 16 0.0039
360 BLOOD BILIRUBIN INCREASED 105 0.0039
361 ATRIAL FLUTTER 31 0.0039
362 BLOOD CHLORIDE DECREASED 10 0.0039
363 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 37 0.0039
364 RHINOVIRUS INFECTION 15 0.0039
365 BONE MARROW FAILURE 78 0.0038
366 INFLAMMATORY MARKER INCREASED 19 0.0038
367 DELIRIUM 133 0.0038
368 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 10 0.0038
369 PNEUMOTHORAX 60 0.0038
370 URINE OUTPUT DECREASED 33 0.0038
371 LACUNAR INFARCTION 9 0.0038
372 HYPOTHERMIA 38 0.0037
373 CANDIDIASIS 15 0.0037
374 DIABETES INSIPIDUS 9 0.0037
375 VENTRICULAR HYPOKINESIA 12 0.0037
376 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 19 0.0037
377 ORGAN FAILURE 15 0.0037
378 HEPATIC NECROSIS 14 0.0037
379 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0037
380 EPSTEIN-BARR VIRUS INFECTION 23 0.0037
381 LEUKOPENIA 184 0.0037
382 PROTHROMBIN TIME PROLONGED 22 0.0037
383 LIVER INJURY 90 0.0037
384 FIBRIN D DIMER INCREASED 13 0.0037
385 SUBDURAL HAEMORRHAGE 10 0.0037
386 SEROTONIN SYNDROME 70 0.0036
387 TRANSAMINASES INCREASED 81 0.0036
388 VENTRICULAR TACHYCARDIA 60 0.0036
389 RALES 21 0.0036
390 CARDIAC FAILURE ACUTE 24 0.0036
391 DERMATITIS EXFOLIATIVE 18 0.0036
392 HYPERKALAEMIA 126 0.0036
393 CHEST X-RAY ABNORMAL 11 0.0036
394 LYMPHOCYTE COUNT DECREASED 63 0.0036
395 PULMONARY TOXICITY 25 0.0035
396 DISSEMINATED TUBERCULOSIS 9 0.0035
397 CACHEXIA 18 0.0035
398 HYDROCEPHALUS 19 0.0035
399 FAILURE TO THRIVE 18 0.0035
400 ALTERED STATE OF CONSCIOUSNESS 75 0.0035
401 HYPERREFLEXIA 12 0.0034
402 APHASIA 104 0.0034
403 CATHETER SITE INFECTION 13 0.0034
404 FLUID OVERLOAD 50 0.0034
405 ALANINE AMINOTRANSFERASE INCREASED 209 0.0034
406 HYPOMAGNESAEMIA 47 0.0034
407 PNEUMONITIS 91 0.0033
408 CARDIOPULMONARY FAILURE 13 0.0033
409 CHRONIC GRAFT VERSUS HOST DISEASE 12 0.0033
410 HYPOKALAEMIA 153 0.0033
411 NEPHRITIS 11 0.0033
412 FAECALOMA 18 0.0033
413 BLOOD ALBUMIN DECREASED 26 0.0033
414 PURULENT DISCHARGE 14 0.0033
415 ELECTROLYTE IMBALANCE 38 0.0033
416 BUNDLE BRANCH BLOCK RIGHT 15 0.0033
417 CEREBRAL ATROPHY 13 0.0033
418 CYTOMEGALOVIRUS INFECTION 54 0.0032
419 HYPOPHOSPHATAEMIA 24 0.0032
420 SUBARACHNOID HAEMORRHAGE 33 0.0032
421 SUPRAVENTRICULAR TACHYCARDIA 31 0.0032
422 NEPHROGENIC ANAEMIA 15 0.0032
423 ABDOMINAL TENDERNESS 16 0.0032
424 PYREXIA 1110 0.0032
425 CARDIOGENIC SHOCK 46 0.0032
426 OESOPHAGITIS 35 0.0032
427 HEPATIC FUNCTION ABNORMAL 117 0.0031
428 MENINGITIS ASEPTIC 14 0.0031
429 HEPATIC FAILURE 94 0.0031
430 BRONCHIECTASIS 21 0.0031
431 RENAL IMPAIRMENT 261 0.0031
432 BLOOD ALKALINE PHOSPHATASE INCREASED 76 0.0031
433 PYODERMA GANGRENOSUM 11 0.0031
434 NECROSIS 17 0.0031
435 INTESTINAL PERFORATION 34 0.0030
436 VENTRICULAR ARRHYTHMIA 11 0.0030
437 PNEUMONIA ASPIRATION 75 0.0030
438 RIGHT VENTRICULAR FAILURE 21 0.0030
439 HYPOTENSION 601 0.0030
440 TRANSPLANT REJECTION 24 0.0030
441 RENAL FAILURE CHRONIC 23 0.0030
442 BLOOD LACTATE DEHYDROGENASE INCREASED 47 0.0030
443 ORAL CANDIDIASIS 39 0.0030
444 DECUBITUS ULCER 24 0.0029
445 TORSADE DE POINTES 23 0.0029
446 SUBCUTANEOUS ABSCESS 14 0.0029
447 C-REACTIVE PROTEIN INCREASED 106 0.0029
448 RENAL FAILURE 386 0.0029
449 TACHYCARDIA 258 0.0029
450 SUSPECTED OFF LABEL USE 13 0.0029
451 CELLULITIS 145 0.0029
452 ORAL DISORDER 21 0.0029
453 ELECTROCARDIOGRAM QT PROLONGED 103 0.0029
454 MALNUTRITION 32 0.0029
455 DIFFUSE LARGE B-CELL LYMPHOMA 22 0.0029
456 ODYNOPHAGIA 17 0.0028
457 CARDIAC ARREST 235 0.0028
458 HYPERCALCAEMIA 35 0.0028
459 HAEMATOCRIT DECREASED 56 0.0028
460 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
461 UROSEPSIS 26 0.0028
462 DEPRESSED LEVEL OF CONSCIOUSNESS 111 0.0028
463 NEUROLOGICAL SYMPTOM 16 0.0028
464 PLATELET COUNT DECREASED 295 0.0028
465 ILEUS 34 0.0027
466 INTERNATIONAL NORMALISED RATIO INCREASED 78 0.0027
467 CEREBRAL ISCHAEMIA 14 0.0027
468 VARICOSE VEIN 14 0.0027
469 ACUTE HEPATIC FAILURE 37 0.0027
470 CONFUSIONAL STATE 436 0.0027
471 ILEUS PARALYTIC 12 0.0027
472 B-CELL LYMPHOMA 9 0.0026
473 HYPOCALCAEMIA 50 0.0026
474 TROPONIN INCREASED 20 0.0026
475 BRONCHOPNEUMONIA 9 0.0026
476 MYELODYSPLASTIC SYNDROME 38 0.0026
477 CONJUNCTIVAL HAEMORRHAGE 10 0.0026
478 SPLENOMEGALY 30 0.0026
479 PNEUMONIA 826 0.0025
480 HEPATOMEGALY 25 0.0025
481 RETINAL HAEMORRHAGE 18 0.0025
482 RESPIRATORY SYNCYTIAL VIRUS INFECTION 22 0.0025
483 DIVERTICULUM INTESTINAL 11 0.0025
484 GENERAL PHYSICAL CONDITION ABNORMAL 17 0.0025
485 CARDIOMYOPATHY 37 0.0025
486 BONE LESION 9 0.0025
487 RHABDOMYOLYSIS 104 0.0025
488 FUNGAL INFECTION 83 0.0025
489 GUILLAIN-BARRE SYNDROME 12 0.0025
490 NEPHROPATHY 23 0.0025
491 IRON DEFICIENCY 11 0.0024
492 HAEMORRHAGE INTRACRANIAL 36 0.0024
493 RED CELL DISTRIBUTION WIDTH INCREASED 10 0.0024
494 TENDERNESS 25 0.0024
495 BRAIN INJURY 24 0.0024
496 METASTASES TO LYMPH NODES 16 0.0024
497 ATAXIA 28 0.0024
498 GENERALISED TONIC-CLONIC SEIZURE 39 0.0024
499 DRUG LEVEL BELOW THERAPEUTIC 13 0.0024
500 CYSTIC FIBROSIS 13 0.0023
501 COLITIS 89 0.0023
502 ECCHYMOSIS 16 0.0023
503 LYMPHOPENIA 33 0.0023
504 HEPATITIS CHOLESTATIC 14 0.0023
505 MOUTH HAEMORRHAGE 17 0.0023
506 LUNG INFECTION 36 0.0023
507 ADRENAL INSUFFICIENCY 28 0.0023
508 NO THERAPEUTIC RESPONSE 28 0.0023
509 CEREBRAL HAEMORRHAGE 82 0.0023
510 PULMONARY FUNCTION TEST DECREASED 10 0.0023
511 LIVER FUNCTION TEST INCREASED 49 0.0023
512 PULMONARY OEDEMA 102 0.0023
513 CHOLANGITIS 14 0.0023
514 GAMMA-GLUTAMYLTRANSFERASE INCREASED 50 0.0023
515 ASCITES 66 0.0022
516 SUBDURAL HAEMATOMA 32 0.0022
517 WHITE BLOOD CELL COUNT DECREASED 242 0.0022
518 DRUG INTERACTION 351 0.0022
519 HYPONATRAEMIA 124 0.0022
520 CARDIO-RESPIRATORY ARREST 92 0.0022
521 ANAEMIA 419 0.0022
522 ARTHRITIS BACTERIAL 9 0.0022
523 OXYGEN SATURATION DECREASED 123 0.0022
524 MYOCARDITIS 25 0.0022
525 SINUS BRADYCARDIA 21 0.0022
526 SPINAL OSTEOARTHRITIS 19 0.0022
527 ATRIAL FIBRILLATION 209 0.0021
528 ERYTHEMA MULTIFORME 20 0.0021
529 PERFORMANCE STATUS DECREASED 10 0.0021
530 TRICUSPID VALVE INCOMPETENCE 17 0.0021
531 ACUTE PULMONARY OEDEMA 12 0.0021
532 MYELOSUPPRESSION 77 0.0021
533 MELAENA 47 0.0021
534 PERIPHERAL VASCULAR DISORDER 11 0.0021
535 MITRAL VALVE INCOMPETENCE 24 0.0021
536 CHOLECYSTITIS ACUTE 12 0.0021
537 MYOSITIS 19 0.0021
538 AORTIC VALVE INCOMPETENCE 9 0.0021
539 HYPERGLYCAEMIA 77 0.0021
540 CARDIAC TAMPONADE 10 0.0021
541 PROTEINURIA 40 0.0021
542 PARTIAL SEIZURES 11 0.0021
543 LIVER DISORDER 93 0.0021
544 SKIN MASS 14 0.0021
545 PULMONARY MASS 31 0.0021
546 POLYURIA 17 0.0021
547 POSTOPERATIVE WOUND INFECTION 14 0.0021
548 ABSCESS 33 0.0021
549 HEPATIC ENCEPHALOPATHY 19 0.0020
550 CHOLECYSTITIS 24 0.0020
551 JAUNDICE 54 0.0020
552 HEPATITIS ACUTE 13 0.0020
553 HYPOPHAGIA 51 0.0020
554 INTERSTITIAL LUNG DISEASE 96 0.0020
555 END STAGE RENAL DISEASE 36 0.0020
556 CENTRAL NERVOUS SYSTEM LESION 27 0.0020
557 PETIT MAL EPILEPSY 10 0.0020
558 ISCHAEMIA 9 0.0020
559 HAEMATURIA 67 0.0020
560 MENINGITIS 13 0.0019
561 APPENDICITIS 18 0.0019
562 PELVIC FRACTURE 15 0.0019
563 VENTRICULAR EXTRASYSTOLES 20 0.0019
564 EOSINOPHIL COUNT INCREASED 16 0.0019
565 PETECHIAE 20 0.0019
566 RESPIRATORY RATE INCREASED 17 0.0019
567 MULTIPLE INJURIES 12 0.0019
568 WHITE BLOOD CELL COUNT INCREASED 73 0.0019
569 VENTRICULAR FIBRILLATION 21 0.0019
570 BRADYCARDIA 100 0.0019
571 EMPHYSEMA 19 0.0019
572 EJECTION FRACTION DECREASED 29 0.0019
573 ANAL ABSCESS 10 0.0019
574 MYOCARDIAL ISCHAEMIA 21 0.0018
575 DISORIENTATION 73 0.0018
576 REFUSAL OF TREATMENT BY PATIENT 12 0.0018
577 NERVOUS SYSTEM DISORDER 57 0.0018
578 ASPIRATION 20 0.0018
579 BODY TEMPERATURE INCREASED 37 0.0018
580 APNOEA 14 0.0018
581 HAEMOPTYSIS 50 0.0018
582 PERITONITIS 37 0.0018
583 BLOOD POTASSIUM INCREASED 29 0.0018
584 FACE OEDEMA 30 0.0018
585 BLOOD CALCIUM DECREASED 20 0.0018
586 COMA 84 0.0018
587 HAEMOGLOBIN DECREASED 181 0.0018
588 FACIAL PARALYSIS 15 0.0018
589 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 18 0.0018
590 PULMONARY CONGESTION 23 0.0017
591 HERPES VIRUS INFECTION 10 0.0017
592 PERICARDIAL EFFUSION 40 0.0017
593 LARGE INTESTINE PERFORATION 12 0.0017
594 DERMATITIS 36 0.0017
595 TRANSFUSION 18 0.0017
596 CATATONIA 9 0.0017
597 PERIPHERAL SENSORY NEUROPATHY 10 0.0017
598 HYPERTRIGLYCERIDAEMIA 10 0.0017
599 CARDIOMEGALY 21 0.0017
600 LIPASE INCREASED 13 0.0017
601 SPINAL COMPRESSION FRACTURE 14 0.0017
602 LETHARGY 97 0.0017
603 DRUG LEVEL DECREASED 17 0.0017
604 ENDOPHTHALMITIS 10 0.0017
605 ACUTE MYOCARDIAL INFARCTION 49 0.0017
606 ARTERIOSCLEROSIS CORONARY ARTERY 11 0.0017
607 HAEMATEMESIS 42 0.0017
608 RESPIRATORY TRACT INFECTION 43 0.0016
609 RENAL CYST 13 0.0016
610 INTESTINAL ISCHAEMIA 9 0.0016
611 STOMATITIS 99 0.0016
612 VASCULITIS 19 0.0016
613 LOWER GASTROINTESTINAL HAEMORRHAGE 12 0.0016
614 PYELONEPHRITIS 14 0.0016
615 INTRACRANIAL PRESSURE INCREASED 9 0.0016
616 UPPER GASTROINTESTINAL HAEMORRHAGE 27 0.0016
617 NEPHROTIC SYNDROME 11 0.0016
618 HYDRONEPHROSIS 12 0.0016
619 BLOOD CREATINE PHOSPHOKINASE INCREASED 46 0.0016
620 GASTROINTESTINAL HAEMORRHAGE 133 0.0016
621 PULMONARY HYPERTENSION 33 0.0016
622 CONDITION AGGRAVATED 479 0.0016
623 SKIN LESION 43 0.0016
624 HALLUCINATION, VISUAL 33 0.0016
625 ENTERITIS 10 0.0016
626 NEUTROPHIL COUNT INCREASED 16 0.0016
627 CIRCULATORY COLLAPSE 26 0.0015
628 MOUTH ULCERATION 32 0.0015
629 PANCREATITIS ACUTE 34 0.0015
630 OEDEMA 82 0.0015
631 HYPERLIPIDAEMIA 18 0.0015
632 MYOPATHY 13 0.0015
633 LYMPHADENOPATHY 53 0.0015
634 TREATMENT FAILURE 124 0.0015
635 METASTASES TO CENTRAL NERVOUS SYSTEM 19 0.0015
636 RED BLOOD CELL COUNT DECREASED 42 0.0015
637 DRUG TOXICITY 20 0.0015
638 DEEP VEIN THROMBOSIS 95 0.0015
639 WOUND INFECTION 16 0.0015
640 AGITATION 107 0.0015
641 RESPIRATORY ARREST 40 0.0014
642 ANAPHYLACTIC REACTION 80 0.0014
643 THERAPY NON-RESPONDER 65 0.0014
644 EMBOLISM 12 0.0014
645 EPILEPSY 44 0.0014
646 RENAL DISORDER 67 0.0014
647 RESPIRATORY DISORDER 43 0.0014
648 CARDIAC FAILURE 115 0.0014
649 SKIN PLAQUE 12 0.0014
650 OFF LABEL USE 1233 0.0014
651 HEPATITIS 36 0.0014
652 PRODUCT USE IN UNAPPROVED INDICATION 346 0.0014
653 HEPATOTOXICITY 31 0.0014
654 INCOHERENT 9 0.0014
655 PERITONITIS BACTERIAL 14 0.0014
656 RENAL INJURY 41 0.0014
657 RHINITIS 11 0.0014
658 INFECTION 196 0.0014
659 HAEMATOMA 35 0.0013
660 NEUROLEPTIC MALIGNANT SYNDROME 16 0.0013
661 MUSCLE TWITCHING 31 0.0013
662 FISTULA 15 0.0013
663 DISEASE PROGRESSION 157 0.0013
664 THERAPY CHANGE 13 0.0013
665 RASH ERYTHEMATOUS 63 0.0013
666 HALLUCINATION 99 0.0013
667 GLOMERULAR FILTRATION RATE DECREASED 16 0.0013
668 GASTRITIS 34 0.0013
669 POST PROCEDURAL HAEMORRHAGE 15 0.0013
670 RESTLESSNESS 47 0.0013
671 SEIZURE 148 0.0013
672 FLANK PAIN 12 0.0013
673 CHILLS 150 0.0013
674 DUODENAL ULCER 9 0.0013
675 TOXICITY TO VARIOUS AGENTS 215 0.0013
676 CARDIAC MURMUR 11 0.0013
677 DENTAL CARIES 14 0.0013
678 SPUTUM DISCOLOURED 12 0.0013
679 LUNG DISORDER 62 0.0013
680 IMMUNOSUPPRESSION 11 0.0012
681 DYSPHAGIA 118 0.0012
682 PRODUCT PRESCRIBING ISSUE 27 0.0012
683 REBOUND EFFECT 14 0.0012
684 VITAMIN D DEFICIENCY 12 0.0012
685 HAEMARTHROSIS 11 0.0012
686 GENERAL PHYSICAL HEALTH DETERIORATION 142 0.0012
687 DRUG INEFFECTIVE 1605 0.0012
688 PHARYNGITIS 15 0.0012
689 CEREBRAL INFARCTION 29 0.0012
690 HEPATIC STEATOSIS 22 0.0012
691 ORAL HERPES 23 0.0012
692 LIVER FUNCTION TEST ABNORMAL 34 0.0012
693 BLOOD SODIUM DECREASED 22 0.0012
694 LEUKAEMIA 11 0.0012
695 HIATUS HERNIA 15 0.0012
696 BLISTER 63 0.0011
697 BRONCHOSPASM 16 0.0011
698 BREAST CANCER METASTATIC 12 0.0011
699 ORAL PAIN 25 0.0011
700 ANGIOEDEMA 49 0.0011
701 METASTASES TO BONE 18 0.0011
702 CARDIAC FAILURE CONGESTIVE 88 0.0011
703 PULMONARY FIBROSIS 21 0.0011
704 RASH PRURITIC 59 0.0011
705 BLOOD PRESSURE DECREASED 72 0.0011
706 GRAND MAL CONVULSION 10 0.0011
707 DYSKINESIA 44 0.0011
708 MASS 15 0.0011
709 URINARY TRACT INFECTION 183 0.0011
710 THERAPY CESSATION 55 0.0011
711 RASH PAPULAR 24 0.0011
712 SKIN INFECTION 12 0.0011
713 CONVULSION 61 0.0011
714 ARTERIOSCLEROSIS 10 0.0011
715 ABDOMINAL PAIN 246 0.0011
716 DISEASE RECURRENCE 50 0.0011
717 INFUSION RELATED REACTION 69 0.0010
718 ANHEDONIA 27 0.0010
719 PULMONARY EMBOLISM 97 0.0010
720 HYPOGLYCAEMIA 49 0.0010
721 IMMUNODEFICIENCY 15 0.0010
722 RASH GENERALISED 26 0.0010
723 GASTRIC ULCER 19 0.0010
724 SEDATION 26 0.0010
725 OEDEMA PERIPHERAL 121 0.0010
726 ORTHOSTATIC HYPOTENSION 17 0.0010
727 SKIN ULCER 25 0.0010
728 DEHYDRATION 129 0.0010
729 EPISTAXIS 72 0.0010
730 NEOPLASM 11 0.0010
731 CYANOSIS 15 0.0010
732 HEMIPARESIS 16 0.0009
733 POST PROCEDURAL COMPLICATION 18 0.0009
734 MYDRIASIS 12 0.0009
735 UPPER RESPIRATORY TRACT INFECTION 43 0.0009
736 RASH 405 0.0009
737 COVID-19 163 0.0009
738 URINARY RETENTION 31 0.0009
739 MALIGNANT NEOPLASM PROGRESSION 95 0.0009
740 HEPATIC ENZYME INCREASED 63 0.0009
741 RIB FRACTURE 19 0.0009
742 PRODUCTIVE COUGH 44 0.0009
743 CHRONIC KIDNEY DISEASE 70 0.0009
744 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 48 0.0009
745 NODULE 12 0.0009
746 POLYNEUROPATHY 11 0.0009
747 PARALYSIS 13 0.0009
748 MENTAL IMPAIRMENT 22 0.0009
749 DIABETES MELLITUS INADEQUATE CONTROL 16 0.0009
750 COGNITIVE DISORDER 42 0.0009
751 THERAPY PARTIAL RESPONDER 14 0.0009
752 PLASMA CELL MYELOMA 35 0.0009
753 PERICARDITIS 15 0.0009
754 NEOPLASM PROGRESSION 31 0.0009
755 EYELID OEDEMA 10 0.0009
756 IMPAIRED HEALING 28 0.0009
757 INCONTINENCE 9 0.0009
758 DYSARTHRIA 32 0.0008
759 INFLAMMATION 43 0.0008
760 CORONARY ARTERY DISEASE 25 0.0008
761 PRESYNCOPE 20 0.0008
762 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 24 0.0008
763 SKIN FISSURES 16 0.0008
764 SCAR 14 0.0008
765 HYPERTENSION 173 0.0008
766 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
767 ANAPHYLACTIC SHOCK 21 0.0008
768 MUSCLE SPASTICITY 10 0.0008
769 INTENTIONAL PRODUCT USE ISSUE 71 0.0008
770 PALLOR 22 0.0008
771 SECRETION DISCHARGE 10 0.0008
772 HEPATIC CIRRHOSIS 15 0.0008
773 CHOLELITHIASIS 26 0.0008
774 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
775 OSTEOPENIA 12 0.0008
776 SPEECH DISORDER 41 0.0008
777 WHEEZING 46 0.0008
778 MUSCULOSKELETAL CHEST PAIN 12 0.0008
779 DIARRHOEA 500 0.0008
780 RASH MACULAR 27 0.0008
781 DECREASED APPETITE 179 0.0008
782 BRONCHITIS 57 0.0008
783 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
784 HAEMORRHOIDS 15 0.0008
785 OSTEONECROSIS OF JAW 19 0.0008
786 PLATELET COUNT INCREASED 10 0.0008
787 PREMATURE BABY 23 0.0008
788 PULMONARY ARTERIAL HYPERTENSION 11 0.0008
789 ERYTHEMA 156 0.0008
790 IMMUNE SYSTEM DISORDER 10 0.0008
791 CONJUNCTIVITIS 14 0.0008
792 PREMATURE DELIVERY 12 0.0008
793 OBESITY 12 0.0008
794 CHROMATURIA 17 0.0008
795 COUGH 211 0.0008
796 PHOTOPHOBIA 14 0.0007
797 PAIN IN JAW 21 0.0007
798 PANCREATITIS 39 0.0007
799 DYSURIA 27 0.0007
800 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
801 DEAFNESS 19 0.0007
802 EXTRAPYRAMIDAL DISORDER 18 0.0007
803 GOUT 13 0.0007
804 SKIN EXFOLIATION 61 0.0007
805 DYSPNOEA EXERTIONAL 27 0.0007
806 DYSPNOEA 404 0.0007
807 BONE DISORDER 13 0.0007
808 ABDOMINAL DISTENSION 74 0.0007
809 VOMITING 333 0.0007
810 SYNCOPE 70 0.0007
811 HAEMORRHAGE 73 0.0007
812 CONSTIPATION 150 0.0007
813 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
814 MUSCULAR WEAKNESS 76 0.0007
815 DISTURBANCE IN ATTENTION 36 0.0007
816 PHOTOSENSITIVITY REACTION 11 0.0007
817 TOOTHACHE 12 0.0007
818 ASTHENIA 249 0.0007
819 MATERNAL EXPOSURE DURING PREGNANCY 59 0.0007
820 HERPES ZOSTER 38 0.0007
821 SOMNOLENCE 133 0.0007
822 ECONOMIC PROBLEM 10 0.0007
823 TREMOR 109 0.0007
824 ARRHYTHMIA 31 0.0007
825 INSURANCE ISSUE 10 0.0007
826 ECZEMA 34 0.0006
827 DIVERTICULITIS 18 0.0006
828 INJURY 45 0.0006
829 TREATMENT NONCOMPLIANCE 35 0.0006
830 FRACTURE 12 0.0006
831 THROMBOSIS 51 0.0006
832 BLOOD POTASSIUM DECREASED 19 0.0006
833 LOCAL SWELLING 11 0.0006
834 ACCIDENTAL OVERDOSE 23 0.0006
835 EXPOSURE DURING PREGNANCY 39 0.0006
836 URTICARIA 105 0.0006
837 HYPOTHYROIDISM 20 0.0006
838 METASTASES TO LIVER 11 0.0006
839 DIABETIC KETOACIDOSIS 15 0.0006
840 PRESCRIBED OVERDOSE 12 0.0006
841 DYSTONIA 12 0.0006
842 OVERDOSE 132 0.0006
843 MENTAL DISORDER 26 0.0006
844 INTESTINAL OBSTRUCTION 22 0.0006
845 CHEST PAIN 106 0.0006
846 CYSTITIS 18 0.0006
847 FEAR 15 0.0006
848 NEUROPATHY PERIPHERAL 52 0.0005
849 NEPHROLITHIASIS 25 0.0005
850 BACK PAIN 126 0.0005
851 TASTE DISORDER 11 0.0005
852 WOUND 15 0.0005
853 NAUSEA 424 0.0005
854 SWELLING 50 0.0005
855 HYPERSENSITIVITY 99 0.0005
856 URINARY INCONTINENCE 15 0.0005
857 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 36 0.0005
858 ISCHAEMIC STROKE 9 0.0005
859 SINUSITIS 51 0.0005
860 OROPHARYNGEAL PAIN 46 0.0005
861 SKIN DISORDER 16 0.0005
862 INFLUENZA 53 0.0005
863 DIABETES MELLITUS 36 0.0005
864 HAEMATOCHEZIA 26 0.0005
865 RETCHING 10 0.0005
866 RECTAL HAEMORRHAGE 20 0.0005
867 OSTEOPOROSIS 19 0.0005
868 THERAPEUTIC RESPONSE DECREASED 28 0.0005
869 SWELLING FACE 30 0.0005
870 LOSS OF CONSCIOUSNESS 59 0.0005
871 GASTROINTESTINAL DISORDER 41 0.0005
872 LOCALISED INFECTION 11 0.0005
873 VIRAL INFECTION 15 0.0005
874 OSTEOARTHRITIS 19 0.0004
875 FULL BLOOD COUNT DECREASED 9 0.0004
876 TYPE 2 DIABETES MELLITUS 15 0.0004
877 PRURITUS 171 0.0004
878 HEART RATE INCREASED 44 0.0004
879 PRODUCT USE ISSUE 82 0.0004
880 NO ADVERSE EVENT 78 0.0004
881 HEART RATE DECREASED 15 0.0004
882 OSTEONECROSIS 14 0.0004
883 MYALGIA 72 0.0004
884 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
885 FALL 140 0.0004
886 LIP SWELLING 14 0.0004
887 THERAPY INTERRUPTED 30 0.0004
888 BLOOD GLUCOSE DECREASED 20 0.0004
889 HYPERHIDROSIS 53 0.0004
890 BONE PAIN 24 0.0004
891 NASAL CONGESTION 24 0.0004
892 FOETAL EXPOSURE DURING PREGNANCY 33 0.0004
893 DEATH 349 0.0004
894 NIGHT SWEATS 13 0.0004
895 ANXIETY 114 0.0004
896 IRRITABILITY 24 0.0004
897 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
898 PROCEDURAL PAIN 11 0.0004
899 ABDOMINAL PAIN LOWER 10 0.0004
900 DYSPHONIA 23 0.0004
901 CEREBROVASCULAR ACCIDENT 65 0.0004
902 AGGRESSION 19 0.0004
903 MEDICATION ERROR 21 0.0004
904 NECK PAIN 21 0.0004
905 FLUID RETENTION 19 0.0004
906 FREQUENT BOWEL MOVEMENTS 10 0.0004
907 PAIN IN EXTREMITY 109 0.0004
908 CONTUSION 35 0.0004
909 MUSCULOSKELETAL PAIN 19 0.0004
910 GAIT INABILITY 12 0.0004
911 RHINORRHOEA 23 0.0004
912 WEIGHT DECREASED 99 0.0004
913 AMNESIA 23 0.0004
914 ABNORMAL BEHAVIOUR 14 0.0004
915 CHEST DISCOMFORT 36 0.0004
916 HOSPITALISATION 54 0.0004
917 ANGINA PECTORIS 10 0.0003
918 SKIN DISCOLOURATION 16 0.0003
919 DRUG WITHDRAWAL SYNDROME 30 0.0003
920 DRUG INTOLERANCE 33 0.0003
921 PALPITATIONS 40 0.0003
922 PSYCHOTIC DISORDER 10 0.0003
923 UNEVALUABLE EVENT 25 0.0003
924 FATIGUE 247 0.0003
925 HYPERSOMNIA 9 0.0003
926 PAIN 190 0.0003
927 HEADACHE 191 0.0003
928 BLOOD GLUCOSE INCREASED 57 0.0003
929 WEIGHT INCREASED 67 0.0003
930 ABDOMINAL PAIN UPPER 60 0.0003
931 FEMUR FRACTURE 9 0.0003
932 EMOTIONAL DISTRESS 35 0.0003
933 SURGERY 16 0.0003
934 BURNING SENSATION 19 0.0003
935 BLOOD PRESSURE INCREASED 41 0.0003
936 CARDIAC DISORDER 25 0.0003
937 VISUAL IMPAIRMENT 33 0.0003
938 WITHDRAWAL SYNDROME 11 0.0003
939 MALAISE 113 0.0003
940 DYSGEUSIA 19 0.0003
941 DEPRESSION 58 0.0003
942 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
943 ASTHMA 28 0.0002
944 DISCOMFORT 15 0.0002
945 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
946 DIZZINESS 117 0.0002
947 OCULAR HYPERAEMIA 11 0.0002
948 BALANCE DISORDER 20 0.0002
949 ADVERSE EVENT 21 0.0002
950 HYPOAESTHESIA 34 0.0002
951 VISION BLURRED 31 0.0002
952 MYOCARDIAL INFARCTION 39 0.0002
953 MOBILITY DECREASED 16 0.0002
954 DRY MOUTH 18 0.0002
955 PERIPHERAL SWELLING 34 0.0002
956 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
957 ARTHROPATHY 12 0.0002
958 ABDOMINAL DISCOMFORT 36 0.0002
959 ADVERSE DRUG REACTION 19 0.0002
960 PARAESTHESIA 33 0.0002
961 ARTHRALGIA 86 0.0002
962 ILL-DEFINED DISORDER 12 0.0002
963 VERTIGO 12 0.0002
964 FLUSHING 20 0.0002
965 GAIT DISTURBANCE 37 0.0002
966 INSOMNIA 51 0.0002
967 MUSCLE SPASMS 35 0.0002
968 DEPRESSED MOOD 10 0.0002
969 SUICIDAL IDEATION 17 0.0002
970 ILLNESS 19 0.0002
971 INFLUENZA LIKE ILLNESS 15 0.0002
972 MEMORY IMPAIRMENT 25 0.0002
973 DRY EYE 9 0.0002
974 UNDERDOSE 13 0.0002
975 ARTHRITIS 14 0.0002
976 NEOPLASM MALIGNANT 11 0.0002
977 FEELING HOT 10 0.0002
978 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
979 INTENTIONAL PRODUCT MISUSE 14 0.0002
980 INJECTION SITE REACTION 11 0.0002
981 EYE PAIN 9 0.0002
982 PRODUCT DOSE OMISSION 10 0.0002
983 DYSPEPSIA 15 0.0002
984 MUSCULOSKELETAL STIFFNESS 13 0.0001
985 INCORRECT DOSE ADMINISTERED 33 0.0001
986 SLEEP DISORDER 10 0.0001
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
988 ALOPECIA 26 0.0001
989 NASOPHARYNGITIS 24 0.0001
990 JOINT SWELLING 15 0.0001
991 PRODUCT DOSE OMISSION ISSUE 36 0.0001
992 DRY SKIN 15 0.0001
993 FEELING ABNORMAL 19 0.0001
994 PSORIASIS 10 0.0001
995 INJECTION SITE PAIN 13 0.0000